Search

Search Constraints

You searched for: Is Part Of Cytometry. Volume 96:Issue 3(2019)

Search Results

1. Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter‐laboratory study: Is it ready for primetime use?. Issue 3 (19th December 2018)

2. BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma. Issue 3 (12th November 2018)

3. Extended immunophenotyping reference values in a healthy pediatric population. Issue 3 (17th October 2018)

7. Minimal residual disease and log‐reduction of plasma cells are associated with superior response after double autologous stem cell transplant in younger patients with multiple myeloma. Issue 3 (13th December 2018)

10. The fraction of CD117/c‐KIT‐expressing erythroid precursors predicts ESA response in low‐risk myelodysplastic syndromes. Issue 3 (9th April 2019)